Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 82

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 6
Chunk 82
---
 the 2004 ASX Plan and 2018 ADS Plan which is described on page 59.

The term and conditions of each grant of options affecting Directors and Key Management Personnel remuneration in this reporting period are as follows:

    Grant date            Date vested and           Expiry date         Exercise      Vested        Value per    
                            exercisable                                  price                   option at grant 
                                                                                                       date      
-----------------------------------------------------------------------------------------------------------------
September 18, 2020   September 18, 2020          September 17, 2025         $0.09   Yes                     $0.03
January 7, 2021      January 6, 2023 onwards     January 6, 2026            $0.03   Partially               $0.03
July 31, 2021        July 31, 2021               July 31, 2024              $0.07   Yes                     $0.03
November 29, 2021    November 29, 2022 onwards   November 29, 2026          $0.02   Partially               $0.02
November 29, 2021    November 29, 2022 onwards   November 29, 2026          $0.04   Partially               $0.02
December 21, 2023    December 21, 2023           December 19, 2026          $0.01   Yes                    $0.005
March 13, 2024       March 13, 2024 onwards      March 13, 2029            $0.004   Partially              $0.004
March 13, 2024       March 13, 2024 onwards      March 13, 2029            $0.005   Partially              $0.004
March 21, 2024       March 21, 2024 onwards      March 21, 2029            $0.003   Partially              $0.004
December 30, 2024*   December 30, 2024           December 30, 2027          $0.01   Yes                    $0.003

Options granted under the plan carry no dividend or voting rights.

When exercisable, each option is convertible into one ordinary share as soon as practical after the receipt by us of the completed exercise form and full payment of such exercise price.

The exercise price of options will be equal to